Norsk Hydro: In discussion with Pål Kildemo

In this episode on the Good Value podcast (recorded Monday 21 February, 2022), Alison Savas is joined by the Executive Vice President and CFO of Norsk Hydro, Pål Kildemo.

Norsk Hydro is a long-term holding in Antipodes’ global portfolios, including the ASX-listed Antipodes Global Shares (Quoted Managed Fund) active-ETF (ASX: AGX1).

Not only is the Oslo-listed company one of the largest aluminium producers in the world, it also has one of the lowest carbon footprints.

Alison and Pål discuss Norsk’s low-carbon, low-cost production, the opportunity for a green aluminium premium, and the structural trends impacting the aluminium market.  

You can subscribe to our podcast on AppleGoogle or Spotify, to be notified as soon as upcoming episodes are published

Subscribe to receive the latest news and insights from the Antipodes team

Subscribe to updates

All content in respect of the Antipodes Global Shares (Quoted Managed Fund) (ARSN 625 560 269), the Antipodes Global Fund – Long (ARSN 118 075 764), the Antipodes Global Fund (ARSN 087 719 515), and the Antipodes Asia Fund (ARSN 096 451 393) is issued by Pinnacle Fund Services Limited ABN 29 082 494 371 AFSL 238 371 (“PFSL”) as responsible entity of the Funds and is prepared by Antipodes Partners Limited (ABN 29 602 042 035) (AFSL 481580) (“Antipodes”) as the investment manager of the Trust. PFSL is not licensed to provide financial product advice.
The information provided is of a general nature only and has been prepared without taking into account your objectives, financial situation or needs. Before making an investment decision in respect of the Funds, you should consider the current product disclosure statement (PDS) and Target Market Determination (‘TMD’) of the Funds and the Fund’s other periodic and continuous disclosure announcements lodged with the ASX, which are available at, and assess whether the Fund is appropriate given your objectives, financial situation or needs. If you require advice that takes into account your personal circumstances, you should consult a licensed or authorised financial adviser.
Neither PFSL nor Antipodes guarantees repayment of capital or any particular rate of return from the Funds. Neither PFSL nor Antipodes gives any representation or warranty as to the currency, reliability, completeness or accuracy of the information contained in this content. All opinions and estimates included in this website constitute judgments of Antipodes as at the date of website creation and are subject to change without notice. Past performance is not a reliable indicator of future performance.

28 February 2022